Meridian Medical Inc.: To Attend ANMA 23rd Annual Convention, Las Vegas, July 30-August 1, 2004

ANMA 2004
VANCOUVER, British Columbia--()--July 28, 2004--Meridian Co., Ltd. ("Meridian") (OTCBB:MRDAF), is pleased to announce that its subsidiary, Meridian Medical Inc. ("MMI" or "the Company") will be attending the American Naturopathic Medical Association's ("ANMA") 23rd annual convention in Las Vegas to promote one of its feature medical diagnostic products: the Digital Pulse Analyzer ("DPA"). The DPA detects early vascular changes - a major risk for cardiovascular disease, the #1 killer in the United States with an estimated economic cost of approximately $298 billion.

More about: ANMA

Founded in 1981, ANMA is dedicated to exploring new frontiers of mind, body, medicine and health. ANMA is aimed not only at individuals with Doctor of Naturopathy (N.D.) or Doctor of Naturopathic Medicine (N.M.D.), but includes a wide variety of other health care fields. With approximately 4,000 members in the United States, Canada, and fourteen foreign countries ANMA is the largest professional naturopathic medical association in America today. ANMA is recognized by the World Organization for Alternative Medicine as the primary organization representing naturopathic medicine in the United States.

The Company will join presenters from around the world to share their knowledge and experience in their respective medical field. This offers the Company the opportunity to form valuable strategic relationships within the industry. The event is being held at the Riviera Hotel & Casino in Las Vegas, with activities beginning Friday morning at 8:00 a.m. and ending at Sunday at 3:00 p.m. The Company will be showcasing its product at Booth 418, with a company representative giving a special one-hour speaking engagement on the features and benefits of the DPA.

More about: Digital Pulse Analyzer ("DPA")

The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry.

ABOUT MERIDIAN

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of it's products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

Contacts

Meridian Co., Ltd.
Debbie Williams
President
(604) 926-3495
Website (Korean): www.meridian.co.kr
Website (North America): www.meridianmedical.ca

Sharing

Contacts

Meridian Co., Ltd.
Debbie Williams
President
(604) 926-3495
Website (Korean): www.meridian.co.kr
Website (North America): www.meridianmedical.ca